These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 19538767

  • 1. Transforming growth factor-beta1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up.
    Sager C, Lopez JC, Duran V, Burek C, Perazzo E.
    Int Braz J Urol; 2009; 35(3):315-23; discussion 323-5. PubMed ID: 19538767
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children.
    El-Sherbiny MT, Mousa OM, Shokeir AA, Ghoneim MA.
    J Urol; 2002 Oct; 168(4 Pt 2):1798-800. PubMed ID: 12352362
    [Abstract] [Full Text] [Related]

  • 4. Endopyelotomy failure is associated with reduced urinary transforming growth factor-beta1 levels in patients with upper urinary tract obstruction.
    Liatsikos EN, Dinlenc CZ, Bernardo NO, Kapoor R, Jabbour ME, Smith AD, Kushner L.
    J Endourol; 2001 Aug; 15(6):567-70. PubMed ID: 11552777
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction.
    Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY.
    Urology; 1997 Nov; 50(5):769-73. PubMed ID: 9372890
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
    Gerber C, Harel M, Lynch ML, Herbst KW, Ferrer FA, Shapiro LH.
    J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
    [Abstract] [Full Text] [Related]

  • 13. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes.
    Taha MA, Shokeir AA, Osman HG, Abd El-Aziz Ael-A, Farahat SE.
    J Urol; 2007 Aug; 178(2):640-6. PubMed ID: 17574624
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The expression of epidermal growth factor and transforming growth factor-beta1 in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children.
    Yang Y, Zhou X, Gao H, Ji SJ, Wang C.
    J Pediatr Surg; 2003 Nov; 38(11):1656-60. PubMed ID: 14614718
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of alfuzosin on renal resistive index, urinary electrolytes and β2 microglobulin levels and TGF β-1 levels of kidney tissue in rats with unilateral ureteropelvic junction obstruction.
    Kose F, Turkyilmaz Z, Sonmez K, Karabulut R, Poyraz A, Gulbahar O, Aral A, Damar C, Kaya C, Can Basaklar A.
    Ren Fail; 2016 Sep; 38(8):1283-90. PubMed ID: 27402370
    [Abstract] [Full Text] [Related]

  • 19. Dynamic renal scintigraphy in children with vesicoureteral reflux and suspected coexisting ureteropelvic junction obstruction.
    Stauss J, Connolly LP, Connolly SA, Zurakowski D, Treves ST, Peters CA.
    J Urol; 2003 Nov; 170(5):1966-70. PubMed ID: 14532835
    [Abstract] [Full Text] [Related]

  • 20. Urinary biomarkers in hydronephrosis.
    Madsen MG.
    Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.